ABCB1 and cancer: Calebin-A has potential as an adjuvant for cancer therapy, increasing the effectiveness of currently used cancer treatments, as it has been shown to directly inhibit P-glycoprotein and has been co-administered with vincristine to treat multidrug-resistant human gastric cancer cells.